GL1X · GenesisL1 explorer

MolNFT v1 · #144027 · protein

Linked KDM5A jmj domain bound to the inhibitor (R)-N-(1-(3-isopropyl- 1H-pyrazole-5-CARBONYL)PYRROLIDIN-3-YL)CYCLOPROPANECARBOXAMIDE (compound N54)

6BH2 · Lysine-specific demethylase 5A, linked KDM5A jmj domain: “Linked KDM5A jmj domain bound to the inhibitor (R)-N-(1-(3-isopropyl…”. X-ray diffraction, 2 ligands (90V, MN), 3 pockets (best druggability 0.69). MolNFT v1 #144027 on…

PDB
6BH2
Type
protein
Length
295 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysine-specific demethylase 5A, linked KDM5A jmj domain
EC
1.14.11.-
UniProt
P29375
Ligands
90V, MN
Pockets
3 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysine-specific demethylase 5A, linked KDM5A jmj domain (EC 1.14.11.-)protein29530% helix, 24% strandP29375

Ligands and binding sites

  • 90V · N-{(3R)-1-[3-(propan-2-yl)-1H-pyrazole-5-carbonyl]pyrrolidin-3-yl}cyclopropanecarboxamide · ligand · chains A
  • MN · Manganese (II) ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · 5 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13860.690.8254MN, GOL, 90V
2890.410.7819empty
3610.340.7722empty

Compared structures

  • 6BH2 · LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR… · the same entry in another collection · chain A against A, TM-score 1.00
  • P29375 · AlphaFold monomer V2.0 prediction for lysine-specific demethylase 5A (P29375) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.